Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:59 PM
3.92
0.38%
After-hours: Aug 15, 2025, 06:13 PM EDT

Applied DNA Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-3.34M -2.67M -3.3M 1.88M -4.47M -1.13M -3.62M -3.11M 551.18K -3.84M -664.55K -1.12M -1.76M -4.72M -4.51M -3.45M -1.52M -4.81M
Depreciation & Amortization
118.67K 58.58K 76.98K 134.16K 186.33K 298.95K 329.68K 349.15K 344.5K 338.92K 327.68K 321.19K 320.86K 320.75K 299.87K 247.77K 199.38K 97.41K
Stock-Based Compensation
26.51K 28.97K 30.25K 30.34K 171K 340.7K 341.5K 340.04K 258.6K 93.75K 272.92K 272.91K 272.92K 1.7M 36.83K 410.43K 649.25K 571.5K
Other Working Capital
-73.27K 73.27K -376.82K -348.66K -104.08K -2.11K 1.13M -7.41K 274.57K -763.16K -420.4K 363.61K -239.49K 152.27K 28.19K -97.25K -14.77K -268.06K
Other Non-Cash Items
-508.03K -230.99K 164.37K -5.19M 1.28M -3.27M -1.19M 374.57K -3.25M 2.34M -2.94M -1.28M -782.5K 10K 1.05M -13.39K -820.31K 1.77M
Deferred Income Tax
n/a n/a n/a n/a n/a 628.05K 684.12K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
513.93K -513.93K -193.68K -348.66K 30.5K -628.05K 767.6K 681.25K 2.31M -1.31M -255K 534.59K 1.69M -1.01M -1.59M 1.55M -1.78M -1.79M
Operating Cash Flow
-3.19M -3.33M -3.25M -3.49M -3.21M -3.76M -2.68M -1.37M 214.39K -2.38M -3.26M -1.75M -261.89K -3.7M -4.71M -1.25M -3.27M -4.16M
Capital Expenditures
-185.32K -116.88K -371.25K -21.83K -14.83K n/a 117.07K -161.8K -54.34K 20.62K -242.66K -76.67K -65.53K -104.69K -906.42K -502.69K -810.04K -329.54K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a 45K n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -1.04M -137.6K n/a -20.62K n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-185.32K -116.88K -371.25K -21.83K -14.83K n/a -924.67K -161.8K -54.34K 45K -242.66K -76.67K -65.53K -104.69K -906.42K -502.69K -810.04K -329.54K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.67M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a 952.5K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-38.83M n/a n/a n/a n/a -77.76K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
39.81M 508.6K n/a 394.00 80.64K -2.88K n/a n/a n/a n/a 3.7M 75.00 4.09M -300K n/a n/a 8.4K 2.61M
Financial Cash Flow
899.25K 6.31M -390.72K 10.81M 3.02M -35.08K n/a n/a n/a n/a 14.03M 75.00 4.09M 300K -14.7M n/a 13.76M 939.95K
Net Cash Flow
-2.47M 2.86M -4.01M 7.29M -209.41K -3.79M -3.6M -1.53M 160.05K -2.34M 10.53M -1.83M 3.76M -3.81M -5.62M -1.75M 9.68M -3.55M
Free Cash Flow
-3.37M -3.44M -3.62M -3.52M -3.22M -3.76M -2.56M -1.53M 160.05K -2.36M -3.5M -1.83M -327.42K -3.81M -5.62M -1.75M -4.08M -4.49M